MD+DI is looking for professionals working in the medical device and diagnostics industry to contribute articles on a variety of topics—and you'll get paid for it.
AdvaMed is working with its Chinese counterpart to strengthen China-U.S. relations to help spur medical device innovation.
With FDA approval for MRI-conditional labeling for the Ellipse implantable cardioverter defibrillator, Abbott is quickly closing an important gap that previously existed in St. Jude’s portfolio.
We’re celebrating brilliant, budding minds in the medical technology field. These innovators, all under 30 years old, have racked up outsized achievements.
Less than a month after FDA alerted doctors of patient deaths related to balloon-based obesity procedures, a newer version of Apollo’s Orbera balloon has been approved in Europe.
Teleflex agreed to pay up to $1.1 billion for NeoTract, a hyper-growth company in the urological device market.
ExThera Medical's new blood filter technology received Expedited Access Pathway (EAP) designation, accelerating the FDA approval process for the device ahead of clinical use.
Medtronic entered the next phase of its partnership with Mazor by putting up an additional $40 million equity investment and assuming the global distribution of the Mazor X robot. Analysts say the deal is positive for both companies but negative for competitors like NuVasive that lack a robotics system.
A new FDA approval could help Becton, Dickinson and Company shareholders see the long-term value of the company's $24 billion pending acquisition of C.R. Bard.
Longtai Medical agreed to convert a $2 million distributor deposit into equity, signaling confidence in Titan's surgical robot.
A victim of its own success, the medical device conglomerate is racing to add production capacity for the sensors used as part of its insulin pump systems. Marie Thibault Demand for Medtronic's diabetes devices is soaring. So why has the popularity of its continuous glucose monitoring...
While most small medical device companies focus on one disease area, PAVmed is building a product portfolio that spans several fields and optimizes treatment using approaches from other specialties.
The National Capital Consortium for Pediatric Device Innovation extended this year's "Make Your Medical Device for Kids" competition to Thursday. A 2014 winner of the contest shares his success story.
Mylan finalized a $465 million DOJ settlement in an effort to put its EpiPen drama in the rearview mirror. Amanda Pedersen Mylan CEO Heather Bresch said the company's finalized settlement brings closure for Mylan and its stakeholders. The $465 million settlement...